Suma S, Jabir PK, Sai Sailesh Kumar, Syed Sadat Ali, Anita Choudhary, Mahadik VK
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Anger is the most powerful form of emotional expression across all living beings. The primary emotion intends to convey inconvenience or nonacceptance of a certain behaviour or occurrence; it may also represent buried guilt, inefficiency, and a disguised form of expression that is always considered offensive. Smoothing herbs, including Bupleuri Radix and Cyperi Rhizoma, were frequently used in animal models and proved to depict anti-anger properties or effects. Drugs like Risperidone, aripiprazole, and lurasidone have considerable effects in reducing anxiety and anger in a heterogeneous group of neuropsychiatric disorders. Cognitive behaviour therapy, psychotherapy, and dialectical behavioural therapy, nevertheless, have shown promising effects. Further, recent research has provided promising results using electrical vestibular nerve stimulation in the management of negative emotions like stress and anxiety. Vestibular stimulation was known to provide calming effects and improve sleep. The primary aim of anger management would be controlled expression, a targeted approach to enhance parasympathetic dominance in a wholesome manner for the well-being of the individual, society, and mankind
Suma S, Jabir P K, Sai Sailesh Kumar et. al, Anger: A Ban or Boon: A Physiological Perspective. Jr. Med. & Health Sci. 2026; 15(3): 103–105.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| July 14, 2026 | August 17, 2026 | December 30, 2026 |
Sunday 08 November 2026, 02:10:59 (IST)
Download citation
Highlight selected keywords in the article text.
| Received | July 14, 2026 |
| Accepted | August 17, 2026 |
| Published | December 30, 2026 |
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.